Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy

Table 2 Patient characteristics at baseline and six months after device implantation.

	baseline			six months after implantation
	average responders	super-responders	p -value	average responders	super-responders	p -value
LVEF, %	26.7 ± 5.7	24.0 ± 6.7	0.270	33.1 ± 7.9*	50.3 ± 7.4^#	< 0.001
LVEDV, mL	199.8 ± 66.7	145.6 ± 49.4	0.040	155.0 ± 43.4*	103.4 ± 36.1^#	0.004
LVESV, mL	145.3 ± 47.9	110.1 ± 41.6	0.067	105.7 ± 36.1*	53.0 ± 23.1^#	< 0.001

*) p < 0.05 vs. average responders at baseline, ^#) p < 0.05 vs. super-responders at baseline

ISSN: 1476-7120